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Volume 56, Number 1 Abstracts 277Ultrasonic Plaque Echolucency and Embolic Signals Predict Stroke in
Asymptomatic Carotid Stenosis
Topakian R, King A, Kwon SU, and the Aces Investigators. Neurology
2011;77:751-8.
Conclusion: Plaque morphology predicts ipsilateral stroke in asymp-
tomatic carotid stenosis (ACS). The combination of embolic signal (ES)
detection and plaque morphology provides greater prediction than either
measure alone and can identify a high-risk group with an annual stroke rate
of 8% and a low-risk group with a stroke rate of 1% per year.
Summary: Intervention for high-grade ACS is increasingly ques-
tioned. There is evidence that, over the last decade, stroke risk with ACS has
fallen with medical intervention alone (Abbott AL, Stroke 2009;40:e573-
83; Marquardt I et al, Stroke 2010;41:e11-7). Nevertheless, although the
percentage of patients with ACS who actually have a stroke is small, most
ipsilateral strokes in patients with carotid stenosis are unheralded (Inzitari D
et al, N Engl J Med 2000;342:1693-700). In this study, the authors
examined the predictive value of a score based on plaque morphology and
detection of ES with transcranial Doppler. Data were derived from the
prospective, observational, international multicenter Asymptomatic Carotid
Emboli Study (ACES). This study included 435 subjects with ACS 70%
with baseline ultrasound images and transcranial Doppler data available.
Prospective follow-up was for 2 years. Plaque morphology was graded using
a classification system proposed by Geroulakos et al (Br J Surg 1993;80:
1274-7). In this system, type 1 plaques are uniformly echolucent, type 2
plaques are predominately echolucent (50% of the plaque), type 3 plaques
are predominately echogenic (50% of the structure of the plaque), type 4
plaques are uniformly echogenic, and type 5 plaques cannot be classified
because of heavy calcification or poor-quality images. Overall, type 1 and
type 2 plaques are considered echolucent and type 3 and 4 plaques echo-
genic. In this study, 164 of the plaques (37.7%) were graded echolucent. At
baseline, plaque echolucency was associated with an increased risk of ipsilat-
eral stroke alone (hazard ratio, 6.43; 95% confidence interval, 1.36-30.44;
P .019). Combining plaque echolucency and ES positivity at baseline was
associated with a marked increased risk of ipsilateral stroke alone (hazard
ratio, 10.61; 95% confidence interval, 2.98-37.82; P  .003). Controlling
for risk factors such as degree of carotid stenosis and antiplatelet medication
did not alter this association.
Comment: Data justifying prophylactic endarterectomy for asymp-
tomatic carotid stenosis is now quite old. Results of surgery, angioplasty, and
medical management of asymptomatic carotid stenosis are likely better now
than a decade or two ago, but at a minimum, 20 carotid interventions for
patients with asymptomatic carotid stenosis are needed to prevent one major
stroke. There clearly needs to be a better approach to selecting patients with
asymptomatic carotid stenosis for prophylactic endarterectomy. However, I
doubt the approach presented here will be the answer. The classification
system of carotid plaques described by Geroulakos et al has been available for
many years and is simply not used, and embolic signal monitoring, as
performed in the ACES study, is too cumbersome to be incorporated into
routine clinical practice.
Asymptomatic Carotid Artery Stenosis and Cognitive Outcomes After
Coronary Artery Bypass Grafting
Norkienë I, Samalavic`ius R, Ivaškevicˇius J, et al. Scand Cardiovasc J 2011;
45:169-73.
Conclusion: Asymptomatic 50% carotid stenosis is a risk factor for
cognitive decline after coronary artery bypass grafting (CABG).
Summary: Patients anticipate CABG will improve their quality of life
(Koch CG et al, Semin Cardiothorac Vasc Anesth 2008;12:203-17). Pres-
ervation and improvement of psychologic emotional well-being enhances
quality of life. Neuropsychologic disorders are being more frequently ad-
dressed in the care of the postoperative patient. Cerebrovascular disease and
coronary artery disease potentially put patients at risk for cognitive decline.
In this report, the authors correlate asymptomatic carotid stenosis with
cognitive decline after coronary artery bypass grafting (CABG). They sought
to detect the incidence of cognitive decline after CABG, identify risk factors
associated with such cognitive decline, and investigate a possible link be-
tween cognitive performance and asymptomatic carotid stenosis.
The authors studied 127 patients who underwent CABG. The patients
underwent a neuropsychologic examination that included seven cognitive
tests and two scales for evaluation of mood disorders. The patients were
tested the day before surgery and before discharge from the hospital. Testing
revealed that early postoperative decline was common and was detected in
46% of patients. Postoperative cognitive decline was associated with low
cardiac output syndrome perioperatively (P  .05), postoperative bleeding
(P  .03), longer duration of surgery (P  .02), and longer intensive care
unit stay and postoperative mechanical ventilation time (P .05). Multivar-
iate regression analysis indicated carotid artery stenosis of50%was a strong
independent predictor of postoperative cognitive decline (odds ratio, 26.9;
95% confidence interval, 6.44-112.34).Comment: The authors’ data indicate an association between cogni-
tive decline after CABG and the presence of 50% carotid stenosis. One
r
oannot, however, derive from this data that the carotid stenosis itself leads
o cognitive decline after CABG. Indeed, we know that repair of asymptom-
tic carotid stenosis before CABG has minimal, if any, impact on more
bvious clinical end points such as stroke and death after CABG. This study
id not have cerebral imaging before and after CABG to correlate with the
europhysiologic testing. At this time, it seems more likely the carotid
tenosis is more of a marker for more advanced preexisting intracranial
ascular disease potentially associated with cognitive decline after CABG
han a potential target for intervention to decrease cognitive decline after
ABG.
ystematic Review of Exercise Training or Percutaneous Transluminal
ngioplasty for Intermittent Claudication
rans FA, Bipat S, Reekers JA, et al. Br J Surg 2012;99:16-28.
Conclusion: The combination of percutaneous transluminal angio-
lasty (PTA) and exercise therapy (ET) may be superior to ET or PTA alone
or treatment of intermittent claudication.
Summary: One goal in patients with intermittent claudication is to
mprove walking distance with the thought that improved walking distance
ill improve quality of life. PTA, surgery, drugs, and ET all potentially
mprove symptoms in patients with intermittent claudication. Systematic
eviews have demonstrated superiority of supervised ET (SET) over unsu-
ervised ET for increasing pain-free and maximum walking distance (Ben-
ermacher BL et al, Cochrane Database Syst Rev 2006;CD005263; Wind J
t al, Eur J Vasc Endovasc Surg 2007;34:1-9). A Cochran review (Fowkes
G et al, Cochrane Database Syst Rev 2000;CD000017) indicted greater
hort-term benefit with PTA than ET in patients with intermittent claudi-
ation, but that the effect was not sustained after 1 to 2 years. A second
eview found medical treatment (home or SET, plus risk factor modifica-
ion) resulted in longer walking distances than PTA at 1 to 2 years (Wilson
E, Ann Vasc Surg 2010;24:498-502). The authors noted that since this
eview, six additional randomized clinical trials have compared PTA and ET.
hey performed a systematic review to summarize the results of all currently
vailable randomized clinical trials comparing PTA with ET therapy, with
he goal to obtain the best estimate of the relative effectiveness of PTA and
T.
This was a systematic review of relevant randomized clinical trials
dentified from the MEDLINE, Embase, and Cochrane Library Databases.
o be included in the review, the trial had to compare PTA with ET in
atients with intermittent claudication secondary to aortoiliac or femoral
opliteal occlusive disease, or both. There were 258 initial articles identified,
ith 11 (reporting data on eight trials) meeting inclusion criteria, including
ne trial with isolated aortoiliac obstruction, three trials with femoropopli-
eal disease, and five with combined lesions. Two trials compared PTA with
dvice for ET, four trials compared PTA with SET, two trials compared PTA
lus SET with SET alone, and two trials compared PTA plus SET with PTA
lone. The authors concluded that heterogeneity precluded pooling of the
ata even though the end points in most trials were walking distance and
uality of life. Their analysis indicated the effectiveness of PTA and ET was
quivalent, although PTA plus ET provided greater improvement of walking
istance and some domains of quality of life analysis compared with PTA
lone or ET alone.
Comment: The article provides the most up-to-date information on
he effectiveness of ET and PTA for treatment of intermittent claudication.
ET and PTA can both be effective in improving walking distance in patients
ith claudication. Neither therapy is perfect. ET is noninvasive, relatively
nexpensive, and has less risk compared with PTA. However, PTA may be
ore universally applicable and more quickly effective. Eventual failure rates
re high with PTA, but angioplasty of infrainguinal arteries is a moving
arget, with potential improvements of percutaneous techniques such as
rug-eluting balloons and stents shortly down the road. Two important
uestions not addressed in this study include the cost-effectiveness of each
reatment strategy and the potential for each treatment strategy to convert
atients from claudication to critical limb ischemia with therapy failure.
tenting Versus Surgery in PatientsWith Carotid Stenosis After Previous
ervical Radiation Therapy: Systematic Review and Meta-Analysis
okkema M, den Hartog AG, Bots ML. Stroke 2012;43:793-801.
Conclusions: In patients with carotid stenosis after previous cervical
adiation therapy, carotid artery stenting (CAS) and carotid endarterectomy
CEA) are both feasible revascularization techniques with a low risk of
erebral vascular events. Patients undergoing CEA have more temporary
ranial nerve injuries. There are higher rates of late adverse cerebral vascular
vents and restenosis after CAS than CEA.
Summary: CAS is proposed as a minimally invasive alternative for
atients considered high risk for perioprocedural events with CEA. Patients
ay be high risk from anatomic or clinical factors. One anatomic factor
onsidered by some to impart increased risk for CEA is previous cervical
adiation therapy. However, previous radiation therapy may accelerate rates
f restenosis and subsequent cerebral events in patients treated with CAS or
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July 2012278 AbstractsCEA. The authors preformed an evaluation of perioperative and long-term
outcomes of CAS and CEA in patients with previous cervical radiation
therapy. They used a systematic search strategy with the synonyms “carotid
artery stenosis” and “cervical irradiation” in MEDLINE and Embase data-
bases. Pooled and meta-regression analysis was performed to provide and
compare estimates of outcomes. There were 27 articles comprising 533
patients undergoing radiation therapy (361 CAS and 172 CEA) that fulfilled
inclusion criteria. Pooled analysis showed a perioperative risk for any cerebral
vascular adverse event (CVAE) of 3.9% (95% confidence interval [CI],
2.3%-6.7%) in CAS studies vs 3.5% (95%CI, 1.5%-8.0%) in CEA studies (P
.77). Risk for cranial nerve injury after CEA was 9.2% (95% CI, 3.7%-21.1%)
vs none after CAS. Late outcome showed rates of CVAE favoring CEA (P
.014). The rate of restenosis 50% was higher in patients treated with CAS
compared with CEA (P .003). Of the nine cranial nerve injuries identified
after CEA, only one was permanent, with the remainder resolving within a
few weeks of operation.
Comment: The article questions the commonly held assumption that
CAS is preferred for treatment of carotid stenosis over CEA in patients with
previous cervical radiation. The main problem with this study is a high
possibility of selection bias, with individuals with worse radiation injury
being treated with CAS and those with less injury treated with CEA. The
report therefore cannot indicate a preferred revascularization strategy in
patients requiring treatment of carotid stenosis with previous cervical radi-
ation. The rate of adverse events is relatively low in both groups; therefore,
the choice of treatment with CAS or CEA for carotid stenosis in patients
with previous cervical radiation remains an individual treatment decision
based on physician judgment. Both forms of treatment can provide reason-
able results in appropriate patients.
Retrospective Analysis of Surgery Versus Endovascular Intervention in
Takayasu Arteritis: A Multicenter Experience
Saadoun D, Lambert M, Mirault T, et al. Circulation 2012;125:813-9.
Conclusion: The overall 5-year arterial complication rate after surgical
or endovascular intervention for Takayasu arteritis (TA) is 44%. Complica-
tions are increased with the presence of biologic inflammation in patients
with TA.
Summary: TA is a well known but infrequently encountered large-
vessel arteritis predominately affecting the aorta and its primary branches. It
affects both sexes, and multiple ethnic and racial groups worldwide. Unlike
the temporal arteritis variant of giant cell arteritis, TA responds less well to
glucocorticoid treatment, with remissions occurring in only 40% to 60% of
patients (Kerr GS et al, Ann Intern Med 1994;120:919-29). Of the steroid-
resistant patients, about 40% will respond to additional cytotoxic agents,
leaving approximately 20% of all TA patients resistant to treatment (Hoff-
b
tan GS et al, Arthritis Rheum 2004;50:2296-304). Conventional wisdom
as been that surgical reconstruction for TA does best in the absence of signs
f inflammation and that endovascular treatment for TA is less likely to be
uccessful. Long-term outcomes of endovascular treatment, however, have
ot been reported (Ogino H et al, Circulation 2008;118:2738-47), and a
uantitative assessment of the adequacy of anti-inflammatory treatment for
ascular intervention for TA is also relatively unknown. In particular, data for
ndovascular treatments of this disease consist primarily of case reports from
mall series. In this report, the authors present a relatively large series of TA
atients with long-term outcome analysis after revascularization procedures.
his retrospective multicenter study analyzed the results and outcomes of 79
onsecutive TA patients, 63 women (79.7%), with a median age of 39 years
interquartile range [IQR], 25-50 years). These patients underwent 166
ascular procedures, comprising surgery in 104 (62.7%) and endovascular
epairs in 62 (37.3%). After a follow-up of 6.5 years (IQR 2.2-11.5 years),
here were 70 complications observed, including 53 restenosis, seven throm-
osis, six bleeding complications, and four strokes. Overall, the arterial
omplication-free survival rates at 1, 3, 5, and 10 years were, respectively,
8% (IQR, 69%-88%), 67% (IQR, 57%-78%), 56% (IQR 46%-70%), and 45%
IQR, 34%-60%). The incidence of complications was 37.5% among the 104
urgical procedures and 50% among the 62 endovascular procedures. Mul-
ivariate analysis indicated that inflammation at the time of revascularization
odds ratio, 7.48; 95% confidence interval, 1.42-39.39; P  .04) was
ndependently associated with arterial complications after the vascular pro-
edure. Patients with complications had higher erythrocyte sedimentation
ates (P .001) and serum levels of C-reactive protein levels (P .001) and
brinogen (P .005) compared with patients without arterial complications
fter the vascular procedure.
Comment: Endovascular therapies for TA have traditionally been
egarded as inferior to surgical therapies, with restenosis rates in previous
eries approximately double those of surgical reconstructions (Maksimow-
cz-Mckinnon K et al, Arthritis Rheum 2007;56:1000-9). The current
tudy, which is larger and with longer follow-up than previous studies,
uggests underlying biologic inflammation rather than the type of therapy
sed for TA disease is the most important determinant of complications after
rterial reconstruction in TA patients. Complication rates were 61.5% and
4% for endovascular repair and surgical repair, respectively, when there was
vidence of biologic inflammation. Of course, none of the data here were
andomized, and the patients were treated at various stages of their disease.
n addition, there are insufficient numbers of surgical and endovascular
econstructions for specific arteries and at specific points of disease activity to
ake definitive conclusions about the relative durability of each type of
econstruction. The principal point of the report is that regardless of whether
he patient with TA disease is treated with surgical or endovascular therapy,
iologic inflammation at the time of revascularization dramatically increases
he likelihood of complication.
